Bookmark and Share

J&J Agrees to Pay Over $2.2 Billion in Penalties

Pharmaceutical giant Johnson & Johnson (NYSE: JNJ) has agreed to pay over $2.2 billion to settle criminal and civil claims related to the marketing of antipsychotic drug Risperdal and other medications. The lawsuits alleged that JNJ marketed the medications for off-label uses. The Justice Department also said that the company paid kickbacks to a major pharmacy. JNJ has agreed to pay $485 million in criminal fines and forfeiture and $1.72 billion in civil settlements with the federal government and states.

Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.